A study of dependencies associated with cancer-causing mutations has identified a small molecule that binds to SHOC2 and inhibits RAS signalling in cells carrying NRAS Q61 mutations, a common oncogenic driver in melanoma.
- Zachary J. Hauseman
- Frédéric Stauffer
- Luca Tordella